Journal
INTERNATIONAL JOURNAL OF CANCER
Volume 148, Issue 11, Pages 2724-2735Publisher
WILEY
DOI: 10.1002/ijc.33476
Keywords
pediatric; renal cell carcinoma; survival; treatment
Categories
Funding
- Children's Cancer and Leukaemia Group/Little Princess Trust [CCLGA 2019 27B]
- Children's Cancer and Leukaemie Group/Bethany's Wish [CCLGA 2017 02]
- Great Ormond Street Hospital Children's Charity [W1090]
- Stichting Kinderen Kankervrij [341]
Ask authors/readers for more resources
This study is the first report of pediatric patients with RCC registered by SIOP-RTSG. It found that translocation type RCC was the most common histological subtype, with a 5-year survival rate of 70.5%. Survival rates varied depending on the stage of disease, with metastatic cases showing substantially lower outcomes.
In children, renal cell carcinoma (RCC) is rare. This study is the first report of pediatric patients with RCC registered by the International Society of Pediatric Oncology-Renal Tumor Study Group (SIOP-RTSG). Pediatric patients with histologically confirmed RCC, registered in SIOP 93-01, 2001 and UK-IMPORT databases, were included. Event-free survival (EFS) and overall survival (OS) were analyzed using the Kaplan-Meier method. Between 1993 and 2019, 122 pediatric patients with RCC were registered. Available detailed data (n = 111) revealed 56 localized, 30 regionally advanced, 25 metastatic and no bilateral cases. Histological classification according to World Health Organization 2004, including immunohistochemical and molecular testing for transcription factor E3 (TFE3) and/or EB (TFEB) translocation, was available for 65/122 patients. In this group, the most common histological subtypes were translocation type RCC (MiT-RCC) (36/64, 56.3%), papillary type (19/64, 29.7%) and clear cell type (4/64, 6.3%). One histological subtype was not reported. In the remaining 57 patients, translocation testing could not be performed, or TFE-cytogenetics and/or immunohistochemistry results were missing. In this group, the most common RCC histological subtypes were papillary type (21/47, 44.7%) and clear cell type (11/47, 23.4%). Ten histological subtypes were not reported. Estimated 5-year (5y) EFS and 5y OS of the total group was 70.5% (95% CI = 61.7%-80.6%) and 84.5% (95% CI = 77.5%-92.2%), respectively. Estimated 5y OS for localized, regionally advanced, and metastatic disease was 96.8%, 92.3%, and 45.6%, respectively. In conclusion, the registered pediatric patients with RCC showed a reasonable outcome. Survival was substantially lower for patients with metastatic disease. This descriptive study stresses the importance of full, prospective registration including TFE-testing.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available